The New England journal of medicine
-
Comment Letter
Patient Safety under Flexible and Standard Duty-Hour Rules.
-
Randomized Controlled Trial Multicenter Study
Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer.
Stage III or IVA endometrial cancer carries a significant risk of systemic and locoregional recurrence. ⋯ Chemotherapy plus radiation was not associated with longer relapse-free survival than chemotherapy alone in patients with stage III or IVA endometrial carcinoma. (Funded by the National Cancer Institute; ClinicalTrials.gov number, NCT00942357.).
-
Letter Case Reports
Alemtuzumab for Immune-Related Myocarditis Due to PD-1 Therapy.